HIGHLIGHTS
- who: Kinji Ohno and colleagues from the Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan have published the article: Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genesu2014A Comprehensive Review, in the Journal: (JOURNAL)
- what: CMS is a group of heterogenous disorders with highly variable clinical phenotypes that require specific treatment for specific pathomechanisms (Table 1).
SUMMARY
SomeSLC5A7-CMS, patients with SNAP25-CMS, UNC13A-CMS, DPAGT1-CMS, ALG2-CMS,UNC13A-CMS, MYO9A-CMS, DPAGT1-CMS, SLC25A1-CMS, CHAT-CMS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.